
Dr Arutha Kulasinghe
Faculty of Health,School - Biomedical Sciences,
Research - Biomedical Sciences
Personal details
- Name
- Dr Arutha Kulasinghe
- Position(s)
- Research Fellow
Faculty of Health,
School - Biomedical Sciences,
Research - Biomedical Sciences - IHBI Membership
Institute of Health Biomedical Innovation (IHBI),
IHBI Health Projects,
IHBI Biomedical Sciences - CDA - Discipline *
- Medical Biotechnology, Oncology and Carcinogenesis
- Phone
- +61 7 3138 6227
- arutha.kulasinghe@qut.edu.au
- Location
- View location details (QUT staff and student access only)
- Identifiers and profiles
-
- Qualifications
-
Doctor in Philosophy (Queensland University of Technology)
- Professional memberships
and associations American Association for Cancer Research (AACR Associate Member)
AACR & American Head and Neck Society (AACR AHNS)
Australian Society for Medical Research (ASMR)
Australian Metastasis Research Society (OZMRS)
Brisbane Life Science ECR Symposium (BLISS)
Nanostring GeoMX Translational Leadership Network (GTLN)
Visium Clinical Translational Research Network (CTRN)
COVID-Critical
PREDICT-19
EMCR Forum
Biography
Dr Arutha Kulasinghe completed his Bachelor of Science and Honours majoring in Medical Microbiology at the University of Pretoria (South Africa). In 2014, he undertook his PhD studies in the investigation of circulating tumour cells in head and neck cancers at the Queensland University of Technology (QUT), receiving his doctorate in 2017. In 2019, Dr Kulasinghe began a Peter Doherty NHMRC Early Career Fellowship to develop biomarkers of immunotherapy response in head and neck squamous cell carcinoma (HNSCC) and lung cancer. His research aims to use spatial analysis of the tumour microenvironment and profiling of liquid biopsy (circulating tumour cells/circulating tumour DNA) to identify biomarkers of response to immune checkpoint inhibitors. Dr Kulasinghe is supported by a number of funding agencies including the NHMRC, Cure Cancer, the PA Research Foundation and the GPRWMF.
Experience
- QUT – News – Institute of Health and Biomedical Innovation
- Researcher Success: Dr Arutha Kulasinghe — Funding Cancer Research | Cure Cancer
- Dr Arutha Kulasinghe — Funding Cancer Research | Cure Cancer
- Dr Arutha Kulasinghe: spatial profiling and fighting COVID-19 – The Garnett Passe and Rodney Williams Memorial Foundation (gprwmf.org.au)
- A simple blood test provides personalised therapy for cancer patients. | Fresh Science
- Simple test predicts head & neck cancer spread – YouTube (Channel 7 news)
- Could a simple blood test determine which cancer patients will respond to immunotherapy? – Thinkable.org
- Simple test to predict likely spread of rare cancer (medicalxpress.com)
- RACGP – Simple blood test to predict rare cancers’ likely spread
- Blood test to predict the spread of head and neck cancer (labonline.com.au)
Publications
- Kulasinghe A, Schmidt H, Perry C, Whitfield B, Kenny L, Nelson C, Ebrahimi Warkiani M, Punyadeera C, (2018) A collective route to head and neck cancer metastasis, Scientific Reports p1-8
- Kulasinghe A, Tran T, Blick T, O'Byrne K, Thompson R, Ebrahimi Warkiani M, Nelson C, Kenny L, Punyadeera C, (2017) Enrichment of circulating head and neck tumour cells using spiral microfluidic technology, Scientific Reports p1-10
- Kulasinghe A, Perry C, Kenny L, Ebrahimi Warkiani M, Nelson C, Punyadeera C, (2017) PD-L1 expressing circulating tumour cells in head and neck cancers, BMC Cancer p1-6
- Kulasinghe A, Kenny L, Punyadeera C, (2017) Circulating tumour cell PD-L1 test for head and neck cancers, Oral Oncology p6-7
- Schmidt H, Kulasinghe A, Perry C, Nelson C, Punyadeera C, (2016) A liquid biopsy for head and neck cancers, Expert Review of Molecular Diagnostics p165-172
- Kulasinghe A, Perry C, Boyle G, O'Byrne K, Davies A, Jovanovic L, Nelson C, Punyadeera C, (2016) Epithelial-mesenchymal axis in head and neck cancer cell lines, Journal of Solid Tumors p28-37
- Kulasinghe A, Kenny L, Perry C, Thiery J, Jovanovic L, Vela I, Nelson C, Punyadeera C, (2016) Impact of label-free technologies in head and neck cancer circulating tumour cells, OncoTarget p71223-71234
- Kulasinghe A, Perry C, Ebrahimi Warkiani M, Blick T, Davies A, O'Byrne K, Thompson R, Nelson C, Vela I, Punyadeera C, (2016) Short term ex-vivo expansion of circulating head and neck tumour cells, OncoTarget p60101-60109
- Schmidt H, Kulasinghe A, Kenny L, Punyadeera C, (2016) The development of a liquid biopsy for head and neck cancers, Oral Oncology p8-11
- Kulasinghe A, Perry C, Jovanovic L, Nelson C, Punyadeera C, (2015) Circulating tumour cells in metastatic head and neck cancers, International Journal of Cancer p2515-2523
For more publications by this staff member, visit QUT ePrints, the University's research repository.